These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 7980959)
21. Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia. Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Shen CL; Yeh JK J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):21-7. PubMed ID: 16637226 [TBL] [Abstract][Full Text] [Related]
22. Skeletal effects of constant and terminated use of risedronate on cortical bone in ovariectomized rats. Li QN; Liang NC; Huang LF; Wu T; Hu B; Mo LE J Bone Miner Metab; 1999; 17(1):18-22. PubMed ID: 10084397 [TBL] [Abstract][Full Text] [Related]
23. The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength--assessed in a sexually mature, ovariectomized rat model. Mosekilde L; Danielsen CC; Søgaard CH; McOsker JE; Wronski TJ Bone; 1995 Feb; 16(2):223-30. PubMed ID: 7756051 [TBL] [Abstract][Full Text] [Related]
24. Early effects of prostaglandin E2 on bone formation and resorption in different bone sites of rats. Lin CH; Jee WS; Ma YF; Setterberg RB Bone; 1995 Oct; 17(4 Suppl):255S-259S. PubMed ID: 8579925 [TBL] [Abstract][Full Text] [Related]
25. Prostaglandin E2 adds bone to a cancellous bone site with a closed growth plate and low bone turnover in ovariectomized rats. Ma YF; Ke HZ; Jee WS Bone; 1994; 15(2):137-46. PubMed ID: 8086230 [TBL] [Abstract][Full Text] [Related]
26. The combination therapy with alfacalcidol and risedronate improves the mechanical property in lumbar spine by affecting the material properties in an ovariectomized rat model of osteoporosis. Shiraishi A; Miyabe S; Nakano T; Umakoshi Y; Ito M; Mihara M BMC Musculoskelet Disord; 2009 Jun; 10():66. PubMed ID: 19527501 [TBL] [Abstract][Full Text] [Related]
27. PTH has a more pronounced effect on vertebral bone mass and biomechanical competence than antiresorptive agents (estrogen and bisphosphonate)--assessed in sexually mature, ovariectomized rats. Mosekilde L; Søgaard CH; McOsker JE; Wronski TJ Bone; 1994; 15(4):401-8. PubMed ID: 7917578 [TBL] [Abstract][Full Text] [Related]
28. Beneficial effect of pretreatment and treatment continuation with risedronate and vitamin K2 on cancellous bone loss after ovariectomy in rats: a bone histomorphometry study. Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK J Nutr Sci Vitaminol (Tokyo); 2006 Oct; 52(5):307-15. PubMed ID: 17190100 [TBL] [Abstract][Full Text] [Related]
29. Effect of risedronate on the cortical and cancellous bone mass and mechanical properties in ovariectomized rats: a comparison with the effects of alfacalcidol. Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK J Nutr Sci Vitaminol (Tokyo); 2006 Dec; 52(6):393-401. PubMed ID: 17330501 [TBL] [Abstract][Full Text] [Related]
30. Effect of pre- and post-surgery treatment with risedronate on trabecular bone loss in ovariectomized rats. Iwamoto J; Takeda T; Sato Y; Shen CL; Yeh JK Exp Anim; 2006 Oct; 55(5):457-66. PubMed ID: 17090962 [TBL] [Abstract][Full Text] [Related]
31. Modulation of bone turnover in orchidectomized rats treated with raloxifene and risedronate. Khedr NF; El-Ashmawy NE; El-Bahrawy HA; Haggag AA; El-Abd EE Fundam Clin Pharmacol; 2013 Oct; 27(5):526-34. PubMed ID: 22762129 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidol. Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Yeh JK Exp Anim; 2006 Jul; 55(4):333-42. PubMed ID: 16880680 [TBL] [Abstract][Full Text] [Related]
33. Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats. Ma YF; Jee WS; Ke HZ; Lin BY; Liang XG; Li M; Yamamoto N J Bone Miner Res; 1995 Mar; 10(3):496-505. PubMed ID: 7785472 [TBL] [Abstract][Full Text] [Related]
34. Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. Dalle Carbonare L; Bertoldo F; Valenti MT; Zordan S; Sella S; Fassina A; Turco G; Realdi G; Lo Cascio V; Giannini S J Endocrinol Invest; 2007 Oct; 30(9):739-46. PubMed ID: 17993765 [TBL] [Abstract][Full Text] [Related]
35. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats. Lauritzen DB; Balena R; Shea M; Seedor JG; Markatos A; Le HM; Toolan BC; Myers ER; Rodan GA; Hayes WC J Bone Miner Res; 1993 Jul; 8(7):871-9. PubMed ID: 8352069 [TBL] [Abstract][Full Text] [Related]
36. Long-term disuse osteoporosis seems less sensitive to bisphosphonate treatment than other osteoporosis. Li CY; Price C; Delisser K; Nasser P; Laudier D; Clement M; Jepsen KJ; Schaffler MB J Bone Miner Res; 2005 Jan; 20(1):117-24. PubMed ID: 15619677 [TBL] [Abstract][Full Text] [Related]
37. Additive effect of vitamin K2 and risedronate on long bone mass in hypophysectomized young rats. Iwamoto J; Takeda T; Sato Y; Yeh JK Exp Anim; 2007 Apr; 56(2):103-10. PubMed ID: 17460355 [TBL] [Abstract][Full Text] [Related]
38. Effects of daily administration of prostaglandin E2 and its withdrawal on the lumbar vertebral bodies in male rats. Ke HZ; Jee WS Anat Rec; 1992 Oct; 234(2):172-82. PubMed ID: 1416104 [TBL] [Abstract][Full Text] [Related]
39. Withdrawal of parathyroid hormone treatment causes rapid resorption of newly formed vertebral cancellous and endocortical bone in old rats. Ejersted C; Oxlund H; Eriksen EF; Andreassen TT Bone; 1998 Jul; 23(1):43-52. PubMed ID: 9662129 [TBL] [Abstract][Full Text] [Related]
40. Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid. Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Shen CL; Yeh JK Exp Anim; 2006 Jul; 55(4):349-55. PubMed ID: 16880682 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]